KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBT (2016 - 2026)

Exelixis (EXEL) has 17 years of EBT data on record, last reported at $252.7 million in Q1 2026.

  • For Q1 2026, EBT rose 36.76% year-over-year to $252.7 million; the TTM value through Jan 2026 reached $941.2 million, up 38.08%, while the annual FY2026 figure was $941.2 million, 38.08% up from the prior year.
  • EBT reached $252.7 million in Q1 2026 per EXEL's latest filing, roughly flat from $252.4 million in the prior quarter.
  • Across five years, EBT topped out at $292.8 million in Q2 2024 and bottomed at -$31.4 million in Q4 2022.
  • Average EBT over 5 years is $132.2 million, with a median of $101.7 million recorded in 2023.
  • The widest YoY moves for EBT: up 4329.73% in 2022, down 126.63% in 2022.
  • A 5-year view of EBT shows it stood at -$31.4 million in 2022, then surged by 427.87% to $103.0 million in 2023, then soared by 50.19% to $154.8 million in 2024, then surged by 63.1% to $252.4 million in 2025, then increased by 0.11% to $252.7 million in 2026.
  • Per Business Quant database, its latest 3 readings for EBT were $252.7 million in Q1 2026, $252.4 million in Q4 2025, and $230.4 million in Q3 2025.